Methylprednisolone and Aminocaproic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylprednisolone (methylprednisolone) and Aminocaproic (aminocaproic acid). Common drug interactions include cough among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Methylprednisolone and Aminocaproic. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Aminocaproic?

Aminocaproic has active ingredients of aminocaproic acid. eHealthMe is studying from 737 Aminocaproic users. Check the latest studies of Aminocaproic.



On Jul, 07, 2026

33 people who take Methylprednisolone and Aminocaproic together, and have interactions are studied.

Methylprednisolone and Aminocaproic drug interactions.

What are the common drug interactions of Methylprednisolone and Aminocaproic, by gender? *:

female:

  1. Cough
  2. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  3. Depressed level of consciousness
  4. Drug ineffective
  5. Exophthalmos (bulging or protruding eyeball)
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  8. Headache (pain in head)
  9. Heart rate irregular
  10. Ill-defined disorder

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Renal impairment (severely reduced kidney function)
  4. Renal injury (kidney injury)
  5. Blood bilirubin increased
  6. Body temperature increased
  7. Cardiac failure
  8. Heart valve incompetence (heart's valves do not work correctly)
  9. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  10. Mucosal dryness (dryness of mucous membrane)

What are the common drug interactions of Methylprednisolone and Aminocaproic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pain
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Death
  5. Depression
  6. Fear
  7. Injury
  8. Renal failure (kidney dysfunction)
  9. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  10. Cardiac arrest

20-29:

  1. Asthenia (weakness)
  2. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  3. Back pain
  4. Blood cholesterol increased
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Bronchopleural fistula
  7. Cardiac failure congestive
  8. Cardiomegaly (increased size of heart than normal)
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Cardiorenal syndrome (kidney failure and heart failure)

30-39:

  1. Aortic valve disease
  2. Cardiac failure congestive
  3. Cardiac valve disease (heart valve disease)
  4. Cerebral artery embolism (sudden blocking of an artery by a clot or foreign material)
  5. Cerebral infarction (less blood supply to brain resulting tissue damage)
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Kidney transplant rejection
  8. Leukaemoid reaction (elevated white blood cell count, or leukocytosis, that is a physiological response to stress or infection)
  9. Post procedural complication
  10. Pseudobulbar palsy (inability to control facial movements (such as chewing and speaking))

40-49:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Fascial infection (infection in muscle surrounding tissue)
  3. Folliculitis (infection of hair root)
  4. Groin abscess (pus in groin)
  5. Hyperglycaemia (high blood sugar)
  6. Hypertension (high blood pressure)
  7. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  8. Obesity (having too much body fat)
  9. Perineal abscess
  10. Scrotal abscess (pus in scrotum)

50-59:

  1. Anaemia (lack of blood)
  2. Blood bilirubin increased
  3. Body temperature increased
  4. Haemorrhage (bleeding)
  5. Mucosal dryness (dryness of mucous membrane)
  6. Oedema peripheral (superficial swelling)
  7. Chronic kidney disease
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Headache (pain in head)
  10. Lung adenocarcinoma (a form of non-small cell lung cancer)

60+:

  1. Renal failure (kidney dysfunction)
  2. Renal injury (kidney injury)
  3. Pain
  4. Platelet count decreased
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Renal impairment (severely reduced kidney function)
  8. Stress
  9. Chronic kidney disease
  10. Hallucination, visual (seeing things that aren't there)

What are the existing conditions these people have? *

  1. High Blood Pressure: 8 people, 24.24%
  2. Infection: 7 people, 21.21%
  3. Constipation: 6 people, 18.18%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 18.18%
  5. Pain: 6 people, 18.18%
  6. Stress And Anxiety: 4 people, 12.12%
  7. Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 9.09%
  8. Nausea (feeling of having an urge to vomit): 3 people, 9.09%
  9. Anaemia (lack of blood): 3 people, 9.09%
  10. High Blood Cholesterol: 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and Aminocaproic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methylprednisolone and Aminocaproic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aminocaproic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylprednisolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aminocaproic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone and aminocaproic acid (the active ingredients of Methylprednisolone and Aminocaproic, respectively), and Methylprednisolone and Aminocaproic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: